Lancet (London, England) 2008-03-29
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
ABSTRACT
BACKGROUND
The international standard radiotherapy schedule for early breast cancer delivers 50 Gy in 25 fractions of 2.0 Gy over 5 weeks, but there is a long history of non-standard regimens delivering a lower total dose using fewer, larger fractions (hypofractionation). We aimed to test the benefits of radiotherapy schedules using fraction sizes larger than 2.0 Gy in terms of local-regional tumour control, normal tissue responses, quality of life, and economic consequences in women prescribed post-operative radiotherapy.
METHODS
Between 1999 and 2001, 2215 women with early breast cancer (pT1-3a pN0-1 M0) at 23 centres in the UK were randomly assigned after primary surgery to receive 50 Gy in 25 fractions of 2.0 Gy over 5 weeks or 40 Gy in 15 fractions of 2.67 Gy over 3 weeks. Women were eligible for the trial if they were aged over 18 years, did not have an immediate reconstruction, and were available for follow-up. Randomisation method was computer generated and was not blinded. The protocol-specified principal endpoints were local-regional tumour relapse, defined as reappearance of cancer at irradiated sites, late normal tissue effects, and quality of life. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN59368779.
FINDINGS
1105 women were assigned to the 50 Gy group and 1110 to the 40 Gy group. After a median follow up of 6.0 years (IQR 5.0-6.2) the rate of local-regional tumour relapse at 5 years was 2.2% (95% CI 1.3-3.1) in the 40 Gy group and 3.3% (95% CI 2.2 to 4.5) in the 50 Gy group, representing an absolute difference of -0.7% (95% CI -1.7% to 0.9%)--ie, the absolute difference in local-regional relapse could be up to 1.7% better and at most 1% worse after 40 Gy than after 50 Gy. Photographic and patient self-assessments indicated lower rates of late adverse effects after 40 Gy than after 50 Gy.
INTERPRETATION
A radiation schedule delivering 40 Gy in 15 fractions seems to offer rates of local-regional tumour relapse and late adverse effects at least as favourable as the standard schedule of 50 Gy in 25 fractions.
Related Questions
With the recently reported START (A and B) trial data from the UK, in which patients were allowed to receive hypfractionated doses to nodal regions, i...
New comment by Radiation Oncologist at Willis Knighton Cancer Center ( December 31, 2021)
It has been the policy at our center for years now to offer moderate hypofractionation for RNI, based on the studies linked above. I use 16 fraction regimen. IMN coverage is i...
The Canadian trial showed conventional fractionation might be better in the Grade 3 subset, but this was not shown in the START A/B update. What can e...
New answer by Radiation Oncologist at Rutgers Robert Wood Johnson Medical School (March 14, 2018)
The new ASTRO guideline on whole breast hypofractionaton recently published in Practical Radiation Oncology concluded with 100% consensus that the decision to offer hypofracti...
Would it be acceptable to treat a patient with locally advanced breast cancer (ex pT2N2a) s/p lumpectomy with a short course 4 week treatment ins...
New answer by Radiation Oncologist at Varian Medical Systems/Allegheny health network (February 20, 2020)
We routinely offer HFRT for PMRT for non inflammatory breast cancer or for patients without immediate reconstruction (we offer them the NRG study). We use 40 Gy in 15 fraction...
New answer by Radiation Oncologist at Varian Medical Systems/Allegheny health network (April 3, 2015)
I would say it is not contraindicated. In the clinical studies comparing conventional to hypofractionation, they did not report any increase in late effects on skin or subcuta...
New answer by Radiation Oncologist at University of Texas MD Anderson Cancer Center (May 2, 2015)
In my practice, I routinely offer hypofractionated whole breast radiation plus a boost (40 Gy/15 fractions plus 10-14 Gy in 5-7 fractions, as per START B) to any patient 40 an...
Do you offer hypofractionation to younger women?
New answer by Radiation Oncologist at Rutgers Robert Wood Johnson Medical School (March 14, 2018)
The new ASTRO guideline on Radiation therapy for the whole breast has just been published on line in Practical Radiation Oncology (PRO). With a 93% consensus, the panel indica...
New answer by Radiation Oncologist at Rutgers Robert Wood Johnson Medical School (March 15, 2018)
According to the most recent ASTRO 2018 whole breast guidelines published in PRO, in the absence of strong risk factors for local recurrences, 1000 cGy in 4 to 5 fractions is ...
What dose and fractionation do you use?
New comment by Radiation Oncologist at Varian Medical Systems/Allegheny health network ( September 27, 2023)
No dosimetric criteria but prefer electron boost to reduce the dose to uninvolved target/breast.
Are there any resources comparing whichever value is more relevant for the various breast fractionation schedules (FAST, FAST-Forward, Canadian, UK, 3...
New answer by Radiation Oncologist at Phoenix CyberKnife and Radiation Oncology Center (March 17, 2023)
Is this a trick question?
EQD2 and BED are one and the same. Both are calculated using the linear quadratic model and simply express the same values normalized to diffe...
New comment by Radiation Oncologist at Mayo Clinic Hospital ( May 8, 2023)
We customize our use of bolus and skin doses for both photons and protons. I support covering the skin dose with IMPT protons as you would hope to with a photon plan (bolus or...